Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective (PROMETCO)
A Real World Evidence Prospective Cohort Study in the Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Myriam Koopman
- Phone Number: +31 88 75 56263
- Email: M.Koopman-6@umcutrecht.nl
Study Locations
-
-
-
Buenos Aires, Argentina
- Instituto de Oncología Ángel H. Roffo
-
-
-
-
-
Salzburg, Austria, 5020
- Landeskrankenhaus-Universitaetsklinik
-
-
-
-
-
Edegem, Belgium
- Antwerp University Hospital
-
-
-
-
-
Zagreb, Croatia
- Klinicki Bolnicki Centar (KBC) Zagreb
-
-
-
-
-
Hradec Králové, Czechia
- University Hospital in Hradec Kralove Clinic of Oncology and Radiotherapy
-
-
-
-
-
Paris, France, 75013
- Groupe Hospitalier Pitié Salpêtrière
-
-
-
-
-
Wolfsburg, Germany
- Klinikum Wolfsburg
-
-
-
-
-
Heraklion, Greece
- University Hospital of Heraklion
-
-
-
-
-
Budapest, Hungary
- Del-Pesti Centrum Korhaz OHII, Szent Laszlo Korhaz Telephely
-
-
-
-
-
Dublin, Ireland
- The Adelaide & Meath Hospital-Dublin Incorporating The National Children's Hospital
-
-
-
-
-
Reggio Emilia, Italy, 42123
- Arcispedale Santa Maria Nuova
-
-
-
-
-
Utrecht, Netherlands, 3584 CX
- UMC Utrecht
-
-
-
-
-
Lisboa, Portugal
- Centro Des Estudos Egas Moniz - Hospital Santa Maria
-
-
-
-
-
Ljubljana, Slovenia
- Institute of Oncology Ljubljana
-
-
-
-
-
Madrid, Spain
- Hospital Universitario 12 de Octubre
-
-
-
-
-
Västerås, Sweden
- Västerås Central Hospital
-
-
-
-
-
Zürich, Switzerland
- UniversitaetsSpital Zuerich (University Hospital Zurich)
-
-
-
-
-
Manchester, United Kingdom
- Cancer Research UK, Department of Medical Oncology-The Christie NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18
- Diagnosis of mCRC
- Having had two disease progressions since diagnosis of first metastasis that led to first systemic treatment.
Exclusion Criteria:
- Currently participating in an investigational clinical trial (thus it does not apply to observational cohort studies)
- Currently being treated for other cancer(s)
- Not having mental capacity and/or ability to participate in the study
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall survival
Time Frame: From date of randomization until the date of death from any cause, assessed up to 24 months months
|
metastatic Colorectal Cancer (mCRC) overall survival in real world setting
|
From date of randomization until the date of death from any cause, assessed up to 24 months months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disease control measured by overall response
Time Frame: within 18 months from enrollment
|
Overall response to treatment defined by complete and partial response, stable disease, progression of the disease
|
within 18 months from enrollment
|
|
Quality of life using Patients Reported Outcomes
Time Frame: within 18 months from enrollment
|
Patients Reported Outcomes defined by a modified version of the questionnaire ACCEPTance by the Patients of their Treatment (ACCEPT)
|
within 18 months from enrollment
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DIM-95005-001
- EUPAS33865 (Other Identifier: EU PAS Register Number)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.